India’s ambition to become a $30–35 trillion economy by 2047 places the pharmaceutical sector at the centre of the country’s growth agenda. As global healthcare needs evolve and demand for high-quality, cost-effective drug development rises, India is emerging as a strong force in the Contract Services ecosystem.
India’s own CDMO market is on an accelerated growth path. Favourable cost structures, strong regulatory capabilities, advanced manufacturing technologies and a growing talent base have positioned the country as a preferred global outsourcing partner. Recent research indicates that India’s CDMO market will expand from US$15.63 billion in 2023 to US$44.63 billion by 2029, with the sector expected to capture 4–5% of the global CDMO market, according to a 2025 BCG report.
Globally, the CDMO industry is set for exponential growth, with the U.S. leading at US$54.21 billion in 2023. However, India’s faster trajectory and evolving innovation ecosystem make it a strong contender for future global leadership.
As the CDMO sector scales rapidly and competition intensifies, it becomes essential for organisations to attract and develop specialised talent to ensure quality, speed, compliance and sustained global competitiveness in this high-growth market.
Why Choose CIEL HR?
Extensive Talent Pool
Access to a wide Talent network across India for diverse hiring needs
Industry-Specific Expertise
Trusted HR Solutions Provider with a deep sector expertise
Context-Driven Approach
Aligning HR Solutions with each client’s internal processes
Tech-Enabled Efficiency
AI-driven tools for precision in recruitment and faster TAT
Local Presence & Support:
82 offices across 37 locations for better human connect
End-to-End Hiring Support
Recruitment across all levels and industries for faster, smarter hiring
Solutions: HR Services
Solutions: HR Platforms
